special report: induction of labor and cesarean birth sample · iqi 33 primary cesarean delivery...
TRANSCRIPT
SPECIAL REPORT ©2020 NPIC NPIC.ORG | 1
Special Report: Induction of Labor and Cesarean Birth
INTRODUCTION
Since 2018 and through 2019, there have been at least 8,000 papers, posters and publications published that describe Induction of Labor (IOL) through
multiple lenses—elective, medical indication, advanced maternal age, high-risk, low-risk, multiple gestation and many others. The long-awaited results of
the ARRIVE Trial (labor induction at 39 weeks + 0-4 days gestation versus expectant management in low risk nulliparous women) were published in the
New England Journal of Medicine on August 9, 20181 and created additional discussion surrounding elective induction of labor, particularly induction of
labor at 39 weeks gestation. The overarching findings within this particular study population revealed a lower frequency of cesarean delivery and
hypertensive disorders of pregnancy in elective induction at 39 weeks versus expectant management (p. 521-522). Since then, there has continued to be
considerable discussion surrounding induction of labor and cesarean delivery within NPIC’s membership, and several requests to explore this information
in more detail.
SPECIAL REPORT
For this Special Report, NPIC wanted to be responsive to recent requests for additional data related to induction of labor and cesarean delivery,
particularly trended data over time. Why both of these care measures?
1) Induction of labor continues to generate important conversations within healthcare organizations, and it is important to utilize data to assure
resource availability that can provide a successful labor and delivery outcome (skill/expertise, human and capital resources, room availability,
throughput, etc.).
2) In July 2020, The Joint Commission will begin to report cesarean section rates > 30% on their QualityCheck® site (https://www.qualitycheck.org/).
These rates are based upon a hospital’s core measure data submission for PC-02 Cesarean Birth. The first reporting will include 2018-2019 data,
and organizations will be asked about their cesarean reduction strategies during accreditation surveys effective July 2020.
You will note that NPIC uses an Estimated Rate of Inductions. To better understand this report, it is important to reference how induction of labor is
calculated for this measure (see Appendix for measure definition and associated ICD-10 coding). Induction ICD-10 procedure codes are important to
Sample
SPECIAL REPORT ©2020 NPIC NPIC.ORG | 2
review and document. Clinical care teams responsible for coding can be a tremendous asset to an organization for tracking of induction and supporting a
more accurate estimate of induction rate. The Data Team at NPIC is eager to assist you with developing a strategy to better track both estimated induction
and cesarean delivery rates.
DESCRIPTION OF GRAPHS
The Special Report includes graphs for two measures, NPIC Estimated Rate of Inductions and AHRQ IQI 33 Primary Cesarean Delivery Rate,
Uncomplicated, a primary cesarean delivery rate for low risk multiparous women (see Appendix for additional measure information). Quarterly rates for
your hospital, peer subgroup and the NPIC Database are displayed for the period Q1 2017 – Q2 2019 (10 quarters). The vertical dashed line on each graph
represents the publication of the ARRIVE Trial study in Q3 2018.
Below the graphs for each measure there is a table which includes your hospital’s data by quarter (numerator/ denominator counts and rate), and another
table with peer subgroup and NPIC Database comparisons (average rates) by quarter. Please note, a sizeable drop appears in the Estimated Rate of
Inductions comparison rates displayed for Q4 2017. We suspect this may be related to confusion regarding the use of a new ICD-10 PCS induction code
that became effective for discharges in this quarter.
REFERENCES
1Grobman, W.A., Rice, M.M., Reddy, U.M., Tita, A.T., Silver, R.M., Mallett, G.,…& Macones, G.A. (2018). Labor induction versus expectant management in
low-risk nulliparous women. New England Journal of Medicine, 379, 513-523. Sample
|Induction of Labor and Primary Cesarean Birth, 2017 − 2019 (Q2)
NPIC ID: SA1|
● ●●
●
●
●● ●
●
●
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
0%
10%
20%
30%
40%
2017Q1
2017Q2
2017Q3
2017Q4
2018Q1
2018Q2
2018Q3
2018Q4
2019Q1
2019Q2
● Hospital Subgroup NPIC
Estimated Rate of Inductions
●
●●
● ● ●●
●
●●
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
ARRIVE
STUDY*
0%
10%
20%
30%
40%
2017Q1
2017Q2
2017Q3
2017Q4
2018Q1
2018Q2
2018Q3
2018Q4
2019Q1
2019Q2
● Hospital Subgroup NPIC
IQI 33 Primary Cesarean Delivery Rate, Uncomplicated
metric
numer
2017Q1
denom
2017Q2
rate
2017Q3
150
2017Q4
638
2018Q1
23.5%
2018Q2
150
2018Q3
650
2018Q4
23.1%
2019Q1
184
2019Q2
723
25.4%
73
598
12.2%
159
624
25.5%
214
667
32.1%
250
707
35.4%
202
595
34.0%
203
627
32.4%
243
653
37.2%
Hospital SA1
metric
numer
2017Q1
denom
2017Q2
rate
2017Q3
114
2017Q4
437
2018Q1
26.1%
2018Q2
85
2018Q3
441
2018Q4
19.3%
2019Q1
109
2019Q2
495
22.0%
81
410
19.8%
88
419
21.0%
104
466
22.3%
94
483
19.5%
98
417
23.5%
73
415
17.6%
86
431
20.0%
Hospital SA1
|Subgroup: AR − Academic Regional
* ARRIVE Study publish date: AUG 9, 2018NPIC.ORG | 3
metric
Subgroup
2017Q1
NPIC
2017Q2
26.5%
2017Q3
25.4%
2017Q4
26.4%
2018Q1
24.5%
2018Q2
25.7%
2018Q3
25.0%
2018Q4
19.6%
2019Q1
18.8%
2019Q2
27.2%
25.4%
29.0%
26.0%
27.7%
26.3%
30.0%
27.4%
29.7%
27.4%
33.3%
28.2%
Comparisonsmetric
Subgroup
2017Q1
NPIC
2017Q2
17.4%
2017Q3
18.9%
2017Q4
18.2%
2018Q1
19.0%
2018Q2
18.2%
2018Q3
18.4%
2018Q4
18.1%
2019Q1
19.0%
2019Q2
18.3%
19.0%
18.1%
18.4%
17.2%
18.4%
17.8%
18.5%
17.7%
18.3%
18.2%
18.7%
Comparisons
Sample
SPECIAL REPORT ©2020 NPIC NPIC.ORG | 4
APPENDIX
Estimated Rate of Inductions
This rate reflects all women who delivered and were coded with induction of labor
Numerator
Total cesarean deliveries with a labor of induction code
Denominator
Total deliveries with a labor induction code
Excludes deliveries coded with artificial rupture of membranes (AROM) only
ICD-10-PCS Coding:
AROM – Artificial Rupture of Membranes
10907ZC: Drainage of amniotic fluid, therapeutic from product of conception, via natural or artificial opening
Labor Induction
Cervical Dilators: 0U7C7ZZ – Dilation of cervix, via natural or artificial opening
Cervical Dilators: 0U7C7DZ – Dilation of cervix with intraluminal device, via natural or artificial opening
Oxytocin/Pitocin: 3E033VJ – Introduction of other hormone into peripheral vein, percutaneous approach
Cervical Ripening: 3E0P7GC/3E0P7VZ – Introduction of other therapeutic substance/hormone into female reproductive via natural or artificial opening
Alliance for Innovation on Maternal Health (AIM) ICD-10-PCS Coding Guidelines for Labor Inductions v7-15-2016 were used to develop the NPIC Induction
Rate. https://safehealthcareforeverywoman.org/aim-data/
AHRQ IQI 33: Primary Cesarean Delivery Rate, Uncomplicated
First-time Cesarean deliveries without a hysterotomy procedure per 1,000 deliveries. Excludes deliveries with complications (abnormal presentation,
preterm delivery, fetal death, multiple gestation diagnoses, or breech procedure)
https://www.qualityindicators.ahrq.gov/Modules/IQI_TechSpec_ICD10_v2019.aspx
Sample